Parathyroid hormone (PTH). One of the newer osteoporosis therapies is PTH, marketed as teriparatide (Forteo). It is government approved in the United States and Canada for treating severe osteoporosis. PTH is the first type of drug that actually stimulates new bone formation, but it requires daily injections and can be expensive. 

Calcitonin. This approach to treatment includes Fortical (nasal spray) and Miacalcin (nasal spray and injection, but is indicated for use in women who are more than 5 years after menopause.

Estrogen. Studies have shown that this treatment option (available in many doses and regimens) increases bone mass and decreases the risk for fracture of the spine and hip. But, when osteoporosis is the only issue, other therapies should be considered first, due to concerns about the risks associated with long-term hormone therapy use.

Find more information about osteoporosis here:

NAMS Osteoporosis Position Statement

National Osteoporosis Foundation

NIH Osteoporosis and Related Bone Disease National Resource Center

Next: Prevent Menopausal Joint Pain

Want the latest beauty, fashion and lifestyle tips? Click here to sign up for our fabulous weekly newsletter!